Summary

The global Lipid Nanoparticle CDMO market size is predicted to grow from US$ 6999 million in 2025 to US$ 13780 million in 2031; it is expected to grow at a CAGR of 12.0% from 2025 to 2031.
A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.
United States market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lipid Nanoparticle CDMO players cover GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Lipid Nanoparticle CDMO Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticle CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticle CDMO sales for 2025 through 2031. With Lipid Nanoparticle CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticle CDMO industry.
This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticle CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticle CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticle CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticle CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticle CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticle CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Segmentation by Application:
Gene Therapy
Vaccine Development
Cancer Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript
Creative Biolabs
Merck
Cytiva
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Nippon Fine Chemical
Lipoid

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lipid Nanoparticle CDMO Market Size (2020-2031)
2.1.2 Lipid Nanoparticle CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Lipid Nanoparticle CDMO by Country/Region (2020, 2024 & 2031)
2.2 Lipid Nanoparticle CDMO Segment by Type
2.2.1 Solid Lipid Nanoparticles
2.2.2 Nanostructured Lipid Carriers
2.2.3 Cationic Lipid-Nucleic Acid Complexes
2.3 Lipid Nanoparticle CDMO Market Size by Type
2.3.1 Lipid Nanoparticle CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
2.4 Lipid Nanoparticle CDMO Segment by Application
2.4.1 Gene Therapy
2.4.2 Vaccine Development
2.4.3 Cancer Treatment
2.5 Lipid Nanoparticle CDMO Market Size by Application
2.5.1 Lipid Nanoparticle CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
3 Lipid Nanoparticle CDMO Market Size by Player
3.1 Lipid Nanoparticle CDMO Market Size Market Share by Player
3.1.1 Global Lipid Nanoparticle CDMO Revenue by Player (2020-2025)
3.1.2 Global Lipid Nanoparticle CDMO Revenue Market Share by Player (2020-2025)
3.2 Global Lipid Nanoparticle CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lipid Nanoparticle CDMO by Region
4.1 Lipid Nanoparticle CDMO Market Size by Region (2020-2025)
4.2 Global Lipid Nanoparticle CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lipid Nanoparticle CDMO Market Size Growth (2020-2025)
4.4 APAC Lipid Nanoparticle CDMO Market Size Growth (2020-2025)
4.5 Europe Lipid Nanoparticle CDMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Lipid Nanoparticle CDMO Market Size Growth (2020-2025)
5 Americas
5.1 Americas Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
5.2 Americas Lipid Nanoparticle CDMO Market Size by Type (2020-2025)
5.3 Americas Lipid Nanoparticle CDMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lipid Nanoparticle CDMO Market Size by Region (2020-2025)
6.2 APAC Lipid Nanoparticle CDMO Market Size by Type (2020-2025)
6.3 APAC Lipid Nanoparticle CDMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
7.2 Europe Lipid Nanoparticle CDMO Market Size by Type (2020-2025)
7.3 Europe Lipid Nanoparticle CDMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lipid Nanoparticle CDMO by Region (2020-2025)
8.2 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lipid Nanoparticle CDMO Market Forecast
10.1 Global Lipid Nanoparticle CDMO Forecast by Region (2026-2031)
10.1.1 Global Lipid Nanoparticle CDMO Forecast by Region (2026-2031)
10.1.2 Americas Lipid Nanoparticle CDMO Forecast
10.1.3 APAC Lipid Nanoparticle CDMO Forecast
10.1.4 Europe Lipid Nanoparticle CDMO Forecast
10.1.5 Middle East & Africa Lipid Nanoparticle CDMO Forecast
10.2 Americas Lipid Nanoparticle CDMO Forecast by Country (2026-2031)
10.2.1 United States Market Lipid Nanoparticle CDMO Forecast
10.2.2 Canada Market Lipid Nanoparticle CDMO Forecast
10.2.3 Mexico Market Lipid Nanoparticle CDMO Forecast
10.2.4 Brazil Market Lipid Nanoparticle CDMO Forecast
10.3 APAC Lipid Nanoparticle CDMO Forecast by Region (2026-2031)
10.3.1 China Lipid Nanoparticle CDMO Market Forecast
10.3.2 Japan Market Lipid Nanoparticle CDMO Forecast
10.3.3 Korea Market Lipid Nanoparticle CDMO Forecast
10.3.4 Southeast Asia Market Lipid Nanoparticle CDMO Forecast
10.3.5 India Market Lipid Nanoparticle CDMO Forecast
10.3.6 Australia Market Lipid Nanoparticle CDMO Forecast
10.4 Europe Lipid Nanoparticle CDMO Forecast by Country (2026-2031)
10.4.1 Germany Market Lipid Nanoparticle CDMO Forecast
10.4.2 France Market Lipid Nanoparticle CDMO Forecast
10.4.3 UK Market Lipid Nanoparticle CDMO Forecast
10.4.4 Italy Market Lipid Nanoparticle CDMO Forecast
10.4.5 Russia Market Lipid Nanoparticle CDMO Forecast
10.5 Middle East & Africa Lipid Nanoparticle CDMO Forecast by Region (2026-2031)
10.5.1 Egypt Market Lipid Nanoparticle CDMO Forecast
10.5.2 South Africa Market Lipid Nanoparticle CDMO Forecast
10.5.3 Israel Market Lipid Nanoparticle CDMO Forecast
10.5.4 Turkey Market Lipid Nanoparticle CDMO Forecast
10.6 Global Lipid Nanoparticle CDMO Forecast by Type (2026-2031)
10.7 Global Lipid Nanoparticle CDMO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Lipid Nanoparticle CDMO Forecast
11 Key Players Analysis
11.1 GenScript
11.1.1 GenScript Company Information
11.1.2 GenScript Lipid Nanoparticle CDMO Product Offered
11.1.3 GenScript Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GenScript Main Business Overview
11.1.5 GenScript Latest Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Information
11.2.2 Creative Biolabs Lipid Nanoparticle CDMO Product Offered
11.2.3 Creative Biolabs Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Creative Biolabs Main Business Overview
11.2.5 Creative Biolabs Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Lipid Nanoparticle CDMO Product Offered
11.3.3 Merck Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Cytiva
11.4.1 Cytiva Company Information
11.4.2 Cytiva Lipid Nanoparticle CDMO Product Offered
11.4.3 Cytiva Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cytiva Main Business Overview
11.4.5 Cytiva Latest Developments
11.5 WuXi STA
11.5.1 WuXi STA Company Information
11.5.2 WuXi STA Lipid Nanoparticle CDMO Product Offered
11.5.3 WuXi STA Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 WuXi STA Main Business Overview
11.5.5 WuXi STA Latest Developments
11.6 Carcell
11.6.1 Carcell Company Information
11.6.2 Carcell Lipid Nanoparticle CDMO Product Offered
11.6.3 Carcell Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Carcell Main Business Overview
11.6.5 Carcell Latest Developments
11.7 Croda International
11.7.1 Croda International Company Information
11.7.2 Croda International Lipid Nanoparticle CDMO Product Offered
11.7.3 Croda International Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Croda International Main Business Overview
11.7.5 Croda International Latest Developments
11.8 Detai Biotechnology
11.8.1 Detai Biotechnology Company Information
11.8.2 Detai Biotechnology Lipid Nanoparticle CDMO Product Offered
11.8.3 Detai Biotechnology Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Detai Biotechnology Main Business Overview
11.8.5 Detai Biotechnology Latest Developments
11.9 Waters
11.9.1 Waters Company Information
11.9.2 Waters Lipid Nanoparticle CDMO Product Offered
11.9.3 Waters Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Waters Main Business Overview
11.9.5 Waters Latest Developments
11.10 MicroNano Biologics
11.10.1 MicroNano Biologics Company Information
11.10.2 MicroNano Biologics Lipid Nanoparticle CDMO Product Offered
11.10.3 MicroNano Biologics Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 MicroNano Biologics Main Business Overview
11.10.5 MicroNano Biologics Latest Developments
11.11 Precigenome
11.11.1 Precigenome Company Information
11.11.2 Precigenome Lipid Nanoparticle CDMO Product Offered
11.11.3 Precigenome Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Precigenome Main Business Overview
11.11.5 Precigenome Latest Developments
11.12 Evonik
11.12.1 Evonik Company Information
11.12.2 Evonik Lipid Nanoparticle CDMO Product Offered
11.12.3 Evonik Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Evonik Main Business Overview
11.12.5 Evonik Latest Developments
11.13 Avanti Polar Lipids
11.13.1 Avanti Polar Lipids Company Information
11.13.2 Avanti Polar Lipids Lipid Nanoparticle CDMO Product Offered
11.13.3 Avanti Polar Lipids Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Avanti Polar Lipids Main Business Overview
11.13.5 Avanti Polar Lipids Latest Developments
11.14 Genevant Sciences
11.14.1 Genevant Sciences Company Information
11.14.2 Genevant Sciences Lipid Nanoparticle CDMO Product Offered
11.14.3 Genevant Sciences Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Genevant Sciences Main Business Overview
11.14.5 Genevant Sciences Latest Developments
11.15 Nippon Fine Chemical
11.15.1 Nippon Fine Chemical Company Information
11.15.2 Nippon Fine Chemical Lipid Nanoparticle CDMO Product Offered
11.15.3 Nippon Fine Chemical Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Nippon Fine Chemical Main Business Overview
11.15.5 Nippon Fine Chemical Latest Developments
11.16 Lipoid
11.16.1 Lipoid Company Information
11.16.2 Lipoid Lipid Nanoparticle CDMO Product Offered
11.16.3 Lipoid Lipid Nanoparticle CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Lipoid Main Business Overview
11.16.5 Lipoid Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Lipid Nanoparticle CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Lipid Nanoparticle CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solid Lipid Nanoparticles
Table 4. Major Players of Nanostructured Lipid Carriers
Table 5. Major Players of Cationic Lipid-Nucleic Acid Complexes
Table 6. Lipid Nanoparticle CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
Table 9. Lipid Nanoparticle CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
Table 12. Global Lipid Nanoparticle CDMO Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Lipid Nanoparticle CDMO Revenue Market Share by Player (2020-2025)
Table 14. Lipid Nanoparticle CDMO Key Players Head office and Products Offered
Table 15. Lipid Nanoparticle CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Lipid Nanoparticle CDMO Market Size Market Share by Region (2020-2025)
Table 20. Global Lipid Nanoparticle CDMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Lipid Nanoparticle CDMO Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Lipid Nanoparticle CDMO Market Size Market Share by Country (2020-2025)
Table 24. Americas Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
Table 26. Americas Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
Table 28. APAC Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Lipid Nanoparticle CDMO Market Size Market Share by Region (2020-2025)
Table 30. APAC Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Lipid Nanoparticle CDMO Market Size Market Share by Country (2020-2025)
Table 34. Europe Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Lipid Nanoparticle CDMO
Table 40. Key Market Challenges & Risks of Lipid Nanoparticle CDMO
Table 41. Key Industry Trends of Lipid Nanoparticle CDMO
Table 42. Global Lipid Nanoparticle CDMO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Lipid Nanoparticle CDMO Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Lipid Nanoparticle CDMO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Lipid Nanoparticle CDMO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GenScript Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 47. GenScript Lipid Nanoparticle CDMO Product Offered
Table 48. GenScript Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GenScript Main Business
Table 50. GenScript Latest Developments
Table 51. Creative Biolabs Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 52. Creative Biolabs Lipid Nanoparticle CDMO Product Offered
Table 53. Creative Biolabs Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Creative Biolabs Main Business
Table 55. Creative Biolabs Latest Developments
Table 56. Merck Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 57. Merck Lipid Nanoparticle CDMO Product Offered
Table 58. Merck Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Merck Main Business
Table 60. Merck Latest Developments
Table 61. Cytiva Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 62. Cytiva Lipid Nanoparticle CDMO Product Offered
Table 63. Cytiva Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Cytiva Main Business
Table 65. Cytiva Latest Developments
Table 66. WuXi STA Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 67. WuXi STA Lipid Nanoparticle CDMO Product Offered
Table 68. WuXi STA Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. WuXi STA Main Business
Table 70. WuXi STA Latest Developments
Table 71. Carcell Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 72. Carcell Lipid Nanoparticle CDMO Product Offered
Table 73. Carcell Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Carcell Main Business
Table 75. Carcell Latest Developments
Table 76. Croda International Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 77. Croda International Lipid Nanoparticle CDMO Product Offered
Table 78. Croda International Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Croda International Main Business
Table 80. Croda International Latest Developments
Table 81. Detai Biotechnology Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 82. Detai Biotechnology Lipid Nanoparticle CDMO Product Offered
Table 83. Detai Biotechnology Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Detai Biotechnology Main Business
Table 85. Detai Biotechnology Latest Developments
Table 86. Waters Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 87. Waters Lipid Nanoparticle CDMO Product Offered
Table 88. Waters Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Waters Main Business
Table 90. Waters Latest Developments
Table 91. MicroNano Biologics Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 92. MicroNano Biologics Lipid Nanoparticle CDMO Product Offered
Table 93. MicroNano Biologics Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. MicroNano Biologics Main Business
Table 95. MicroNano Biologics Latest Developments
Table 96. Precigenome Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 97. Precigenome Lipid Nanoparticle CDMO Product Offered
Table 98. Precigenome Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Precigenome Main Business
Table 100. Precigenome Latest Developments
Table 101. Evonik Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 102. Evonik Lipid Nanoparticle CDMO Product Offered
Table 103. Evonik Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Evonik Main Business
Table 105. Evonik Latest Developments
Table 106. Avanti Polar Lipids Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 107. Avanti Polar Lipids Lipid Nanoparticle CDMO Product Offered
Table 108. Avanti Polar Lipids Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Avanti Polar Lipids Main Business
Table 110. Avanti Polar Lipids Latest Developments
Table 111. Genevant Sciences Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 112. Genevant Sciences Lipid Nanoparticle CDMO Product Offered
Table 113. Genevant Sciences Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Genevant Sciences Main Business
Table 115. Genevant Sciences Latest Developments
Table 116. Nippon Fine Chemical Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 117. Nippon Fine Chemical Lipid Nanoparticle CDMO Product Offered
Table 118. Nippon Fine Chemical Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Nippon Fine Chemical Main Business
Table 120. Nippon Fine Chemical Latest Developments
Table 121. Lipoid Details, Company Type, Lipid Nanoparticle CDMO Area Served and Its Competitors
Table 122. Lipoid Lipid Nanoparticle CDMO Product Offered
Table 123. Lipoid Lipid Nanoparticle CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Lipoid Main Business
Table 125. Lipoid Latest Developments


List of Figures
Figure 1. Lipid Nanoparticle CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lipid Nanoparticle CDMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Lipid Nanoparticle CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Lipid Nanoparticle CDMO Sales Market Share by Country/Region (2024)
Figure 8. Lipid Nanoparticle CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Lipid Nanoparticle CDMO Market Size Market Share by Type in 2024
Figure 10. Lipid Nanoparticle CDMO in Gene Therapy
Figure 11. Global Lipid Nanoparticle CDMO Market: Gene Therapy (2020-2025) & ($ millions)
Figure 12. Lipid Nanoparticle CDMO in Vaccine Development
Figure 13. Global Lipid Nanoparticle CDMO Market: Vaccine Development (2020-2025) & ($ millions)
Figure 14. Lipid Nanoparticle CDMO in Cancer Treatment
Figure 15. Global Lipid Nanoparticle CDMO Market: Cancer Treatment (2020-2025) & ($ millions)
Figure 16. Global Lipid Nanoparticle CDMO Market Size Market Share by Application in 2024
Figure 17. Global Lipid Nanoparticle CDMO Revenue Market Share by Player in 2024
Figure 18. Global Lipid Nanoparticle CDMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas Lipid Nanoparticle CDMO Market Size 2020-2025 ($ millions)
Figure 20. APAC Lipid Nanoparticle CDMO Market Size 2020-2025 ($ millions)
Figure 21. Europe Lipid Nanoparticle CDMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Lipid Nanoparticle CDMO Market Size 2020-2025 ($ millions)
Figure 23. Americas Lipid Nanoparticle CDMO Value Market Share by Country in 2024
Figure 24. United States Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Lipid Nanoparticle CDMO Market Size Market Share by Region in 2024
Figure 29. APAC Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
Figure 30. APAC Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
Figure 31. China Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Lipid Nanoparticle CDMO Market Size Market Share by Country in 2024
Figure 38. Europe Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
Figure 39. Europe Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 41. France Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Lipid Nanoparticle CDMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Lipid Nanoparticle CDMO Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Lipid Nanoparticle CDMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Lipid Nanoparticle CDMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 54. APAC Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 55. Europe Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 57. United States Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 58. Canada Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 61. China Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 62. Japan Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 63. Korea Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 65. India Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 66. Australia Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 67. Germany Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 68. France Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 69. UK Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 70. Italy Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 71. Russia Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 74. Israel Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 75. Turkey Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)
Figure 76. Global Lipid Nanoparticle CDMO Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Lipid Nanoparticle CDMO Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Lipid Nanoparticle CDMO Market Size 2026-2031 ($ millions)